Medical Foods Market Size, Share & Trends Analysis Report By Route of Administration, By Product, By Application, By Sales Channel And Segment Forecasts, 2020 - 2027
Medical Foods Market Size, Share & Trends Analysis Report By Route of Administration (Oral, Enteral), By Product (Pills, Powder), By Application, By Sales Channel (Online, Institutional, Retail), And Segment Forecasts, 2020 - 2027
The global medical foods market size is expected to reach USD 30.4 billion by 2027., registering a CAGR of 6.3% over the forecast period. This market is driven by rising geriatric population, increasing prevalence of chronic diseases, and growing focus of policymakers on the management of malnutrition. Dietary management of chronic diseases and rare disorders is the emerging focus area for manufacturers of medical foods, which is also positively impacting the market growth. Patients with chronic diseases develop nutritional deficiencies owing to adverse effects of the disease or the drugs that are used for treatment. Medical foods address these nutritional deficiencies, further driving their consumption.
Moreover, rising prevalence of chronic diseases requiring nutritional management of patients is a key factor which is expected to drive the market growth. According to WHO Noncommunicable Diseases Progress Monitor (2017), chronic diseases such as cancer, diabetes, and cardiovascular diseases are among the leading causes of death globally, accounting for nearly 70.0% of the deaths worldwide. According to Milken Institute, the economic burden of chronic diseases in U.S. was estimated to be USD 1.1 trillion in 2016. A constant rise has been observed in the prevalence of chronic diseases such as Alzheimer’s disease, attention deficit hyperactivity disorder (ADHD), osteoporosis, osteoarthritis, and central nervous system disorders, which require clinical dietary management. Medical foods, also known as foods for special medical purposes, are intended for the dietary management of patients with impaired or limited capacity to digest, ingest, absorb, and metabolize a normal diet and for patients with special nutrient requirements.
Diabetic neuropathy emerged as the largest application segment in 2019 owing to the increase in prevalence of diabetes and rise in the number of patients that are at risk of developing some level of neuropathy.Various initiatives are being undertaken for dietary management of diabetes and are among the key market drivers.
However, the chronic kidney diseases segment is expected to witness the highest growth rate over the forecast period.
Further key findings from the report suggest: • Orally administered medical foods held the largest share in 2019 due to ease in administration along with high commercial availability • Diabetic neuropathy emerged as the leading application segment in 2019; however, chronic kidney disorder is expected to register the highest growth rate over the forecast period owing to the rising prevalence of chronic diseases such as cardiovascular diseases and cancer • Asia Pacific dominated the global market in 2019 due to the presence of several target diseases cases such as obesity and malnutrition in the region • Key players operating in the medical foods market include Danone S.A., Abbott Laboratories, Nestle S.A., Mead Johnsons & Company, LLC, and Fresenius Kabi.
Our reports have been used by over 10K customers, including:
Benign Prostatic Hyperplasia Treatment Market Research Report by Therapeutic Class (5-alpha Reductase Inhibitor, Alpha-blocker, and Phosphodiesterase-5 Inhibitor), by Therapy (Combination Drug Therapy and Mono Drug Therapy), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Healthcare-associated Infectious Disease Diagnostics Market Research Report by Product & Service (Assays, Kits, & Reagents, Instruments, and Services & Software), by Disease Type (Chlamydia Trachomatis Genital Infection and Gonorrhea, Hepatitis, Hospital-Acquired Infections, Human Immunodeficiency Virus, and Human Papillomavirus),...
The anti-money laundering solution market was valued at US$ 1,503.99 million in 2019 and is projected to reach US$ 5,866.51 million by 2027; it is expected to grow at a CAGR of 16.2% from 2020 to 2027. Transaction monitoring is a crucial procedure and key control in anti-money laundering (AML) and countering the financing of terrorism (AML/CFT)...
The viral antigens market was valued at US$ 101.41 million in 2019 and is projected to reach US$ 236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020–2027. The growth of the market is attributed to the increased acceptance of viral antigens in vaccine development, and advancements in image analysis software and informatics...
‘Homozygous familial hypercholesterolemia (HoFH) - Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Homozygous familial hypercholesterolemia (HoFH) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Homozygous...
Mycosis Fungoides Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Mycosis Fungoides Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Mycosis Fungoides Clinical trials scenario. This report provides top line data relating to the clinical...
2020-2025 US Immunohematolgy and NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests This database provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies...
‘Trichomoniasis Market Insights, Epidemiology, and Market Forecast–2030’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends of Trichomoniasis in the United States. The Trichomoniasis market report provides analysis regarding current treatment practices, an emerging...
‘Palmar Hyperhidrosis – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical, and forecasted Palmar Hyperhidrosis epidemiology in the United States. Geographies Covered • The United States Study Period: 2017–2030 Palmar Hyperhidrosis: Understanding The...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.